Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaier Granules with Microwave Ablation in Stage IA NSCLC
NCT07197853Phase 3Not yet recruiting
- Start
- Oct 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of huaier granule in non-small cell lung cancer (NSCLC) (2 arms). Primary endpoint: Progression-Free Survival at 24 months. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
huaier granule
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07197853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07197853.